POLOCAINE-MPF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polocaine-mpf, and when can generic versions of Polocaine-mpf launch?
Polocaine-mpf is a drug marketed by Fresenius Kabi Usa and is included in three NDAs.
The generic ingredient in POLOCAINE-MPF is mepivacaine hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POLOCAINE-MPF?
- What are the global sales for POLOCAINE-MPF?
- What is Average Wholesale Price for POLOCAINE-MPF?
Summary for POLOCAINE-MPF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 114 |
| Patent Applications: | 1,009 |
| DailyMed Link: | POLOCAINE-MPF at DailyMed |
Pharmacology for POLOCAINE-MPF
| Drug Class | Amide Local Anesthetic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for POLOCAINE-MPF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089406-001 | Dec 1, 1986 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089408-001 | Dec 1, 1986 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089409-001 | Dec 1, 1986 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
